Article
Reduction of arthritis and pneumonitis in motheaten mice by soluble tumor necrosis factor receptor.
Arthritis and rheumatism - 1 Jan 1998
Su X, Zhou T, Yang P, Edwards C K, Mountz J D
Abstract excerpt
OBJECTIVE: To determine the effects of anti-tumor necrosis factor (anti-TNF) therapy in the inflammatory and autoimmune disease in motheaten (me/me) mice, which exhibit a Fas apoptosis signaling defect. METHODS: Arthritis, pneumonitis, and mortality were analyzed in me/me mice treated with a novel, soluble, dimeric TNF receptor I (sTNFRI) molecule capable of high-affinity binding and neutralization of TNFalpha....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
